N | 5-YSR (%) | 10-YSR (%) | UNIVARIATE | P-value | MULTIVARIATE | P-value | |
---|---|---|---|---|---|---|---|
HR | HR | ||||||
Variable | |||||||
Age | 1,02 (1,02–1,03) | < 0,0001 | 1,01 (1,01–1,02) | < 0,0001 | |||
Gender | |||||||
Female | 883 | 74 | 60 | Reference | Reference | ||
Male | 1203 | 63 | 50 | 1,33 (1,12–1,58) | 0,0005 | 1,19 (1,00–1,41) | 0,04 |
Melanoma body site | 0,58 | ||||||
Breslow | 1,08 (1,06–1,10) | < 0,0001 | 1,06(1,04–1,08) | < 0,0001 | |||
Ulceration | |||||||
Not | 1126 | 76 | 63 | Reference | Reference | ||
Yes | 960 | 60 | 42 | 1,86 (1,57–2,20) | < 0,0001 | 1,30 (1,08–1,56) | 0,004 |
Number of positive SN | 1,22 (1,06–1,41) | 0,0066 | 0,16 | ||||
SN tumor burden | |||||||
0,01–0,4 mm | 577 | 82 | 68 | Reference | |||
0,42–0,96 mm | 471 | 76 | 58 | 1,27(1,01–1,59) | |||
0,97–3 mm | 586 | 66 | 52 | 1,89 (1,54–2,34) | |||
3,1–35 mm | 452 | 49 | 34 | 3,51 (2,74–4,49) | < 0,0001 | 1,04 (1,03–1,06) | < 0,0001 |
NSN Status | |||||||
Negative | 1633 | 75 | 61 | Reference | |||
Positive | 453 | 46 | 31 | < 0,0001 | 2,06(1,72–2,5) | < 0,0001 |